Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N (2022) Endometrial cancer. Lancet 399(10333):1412–1428

Article  PubMed  Google Scholar 

Amant F, Mirza MR, Koskas M, Creutzberg CL (2018) Cancer of the corpus uteri. Int J Gynecol Obstet 143:37–50

Article  Google Scholar 

Baker-Rand H, Kitson SJ (2024) Recent advances in endometrial cancer prevention, early diagnosis and treatment. Cancers 16(5):1028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17

Article  CAS  PubMed  Google Scholar 

Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Spiegel G, Barakat R, Pearl ML, Sharma SK (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 27(32):5331–5336

Article  PubMed  PubMed Central  Google Scholar 

Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Morita S, Suganuma N, Sugimura K (2009) Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging 36(3):362–372

Article  PubMed  Google Scholar 

Signorelli M, Guerra L, Buda A, Picchio M, Mangili G, Dell’Anna T, Sironi S, Messa C (2009) Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Gynecol Oncol 115(2):231–235

Article  PubMed  Google Scholar 

Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS (2015) Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. J Nucl Med 56(8):1191–1198

Article  CAS  PubMed  Google Scholar 

Nakamura K, Hongo A, Kodama J, Hiramatsu Y (2011) The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer. Gynecol Oncol 123(1):82–87

Article  PubMed  Google Scholar 

Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N (2023) Endometrial Cancer Staging Subcommittee FWsCC: FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet 162(2):383–394

Article  Google Scholar 

Bezzi C, Mapelli P, Mathoux G, Monaco L, Ghezzo S, Bergamini A, Fallanca F, Gajate A, Vasta F, Candotti G, AND MOLECULAR IMAGING: 2022 (2022) Machine Learning-based classification using F-18-FDG PET-derived quantitative parameters in predicting Endometrial Cancer aggressiveness. In: European journal of nuclear medicine : Springer one New York Plaza, Suite 4600, New York, NY, United States;: s244-s244

Takagi H, Sasagawa T, Shibata T, Minato H, Takahashi T (2018) Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma. Taiwan J Obstet Gynecol 57(2):283–288

Article  PubMed  Google Scholar 

Noriega-Álvarez E, Vicente AMG, Londoño GAJ, Bravo WRM, García BG, Castrejón ÁMS (2023) A systematic review about the role of preoperative 18F-FDG PET/CT for prognosis and risk stratification in patients with endometrial cancer. Revista Española de Med Nuclear e Imagen Mol (English Edition) 42(1):24–32

Google Scholar 

Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182(6):1506–1519

Article  CAS  PubMed  Google Scholar 

Bosse T, Peters EE, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Mens JWM, Lutgens LC, Van Der Steen-Banasik EM, Smit VT, Nout RA (2015) Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer–A pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer 51(13):1742–1750

Article  PubMed  Google Scholar 

Bese T, Bicer E, Kosuk AT, Akovali B, Turan H, Kabasakal L, Demirkiran F (2023) The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer. Nucl Med Commun 44(3):204–211

Article  CAS  PubMed  Google Scholar 

Yang Y, Pan Y-Q, Wang M, Gu S, Bao W (2023) Retrospective analysis of the 18F-FDG PET/CT cutoff value for metabolic parameters was performed as a prediction model to evaluate risk factors for endometrial cancer. Radiat Oncol 18(1):196

Article  CAS  PubMed  PubMed Central  Google Scholar 

Serbes ED, Horeweg N, Parra-Herran C, van Rijnsoever R, Jobsen JJ, Jurgenliemk-Schulz I, Kuijsters N, Nout RA, Haverkort MA, Powell ME (2025) Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates. Mod Pathol 38(3):100660

Article  CAS  PubMed  Google Scholar 

Carlson DK, Painter C, Gradecki SE, Ring KL, Williams ES, Mills AM (2025) High-grade endometrial carcinomas with solid basaloid morphology and geographic necrosis lacking definitive pilomatrix-like features: clinicopathologic characteristics including aggressive behavior and novel molecular events. Int J Gynecol Pathol 44(3):199–209

Article  CAS  PubMed  Google Scholar